On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayApr 23, 2024 4:15 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LSX World Congress 2024

  CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has announced that its Chief Executive Officer John Climaco will present at the LSX World Congress 2024. Climaco is slated to present at 4:15 PM (GMT+1) on Monday, April 29, 2024, at the event taking place in London, England. In addition to the presentation, CNSP announced that its management will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference. To view…

Continue Reading

TuesdayApr 23, 2024 3:43 pm

QualityStocksNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Responds to Emergency Request for IV Suramin, Commits to Provide Immediate Access to PAX-101

  PaxMedica (NASDAQ: PXMD), a leading biopharmaceutical company dedicated to advancing treatments for neurological disorders, expects to take immediate action in response to an urgent request for IV suramin from the Ministry of Health (“MOH”) of Malawi, a country in east Africa. The request seeks emergency access to PaxMedica’s recently completed registration batches of PAX-101 (“IV suramin”) to address the critical shortage of medications required to combat the life-threatening sleeping sickness, also known as Trypanosoma brucei rhodesiense, Human African trypanosomiasis (“TBr HAT”), crisis in the region. “The emergency request from the Ministry of Health of Malawi underscores the critical need…

Continue Reading

TuesdayApr 23, 2024 3:07 pm

QualityStocksNewsBreaks – SUIC Worldwide Holdings Ltd (SUIC) Featured in Bell2Bell Podcast

SUIC Worldwide Holdings (OTC: SUIC), a provider of research and development, venture financing and investment for private and public companies, was featured in the latest episode of the Bell2Bell Podcast as part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. SUIC CEO Hank Wang joined the program to provide an overview of the company and its business model. “SUIC Worldwide Holdings targets opportunities to enhance and streamline existing supply chain and financial processes. SUIC is the majority and U.S. operating shareholder of Beneway Holdings Group, which is planning to file an S-1 for an IPO…

Continue Reading

TuesdayApr 23, 2024 2:32 pm

QualityStocksNewsBreaks – Zoned Properties Inc. (ZDPY) Announces $1M Stock Repurchase Program

Zoned Properties (OTCQB: ZDPY), a leading real estate development firm for emerging and highly regulated industries including legalized cannabis, today announced that its board of directors has approved a share repurchase program, pursuant to which the company is authorized to purchase up to $1 million of its common stock over an unlimited time period. “As our business continues to outperform in a challenging overall operating environment, we are thrilled to announce this share repurchase program. The approval of this program demonstrates the management team’s and board’s confidence in our prospects for the future, ongoing operational strength and sound capital structure,”…

Continue Reading

TuesdayApr 23, 2024 10:30 am

Distributed Energy Solutions Provider Correlate Energy Corp. (CIPI) Making Significant Alternative Power Transition an Affordable Reality

Transitioning from fossil fuel dependence to alternative, renewable energy sources has taken on increasing importance amid concerns about the growing consequences of climate change Federal government incentives and experimental projects are helping to drive efforts to transition the United States to greater renewable energy use from carbon-based energy sources Idaho-based Correlate Energy Corp. is a distributed energy solutions company making the transition to renewable energy more accessible to mid-tier companies, particularly those with nationwide portfolios that may create multiple revenue opportunities With proven user-friendly finance models, the company works to strategically develop, and profitably sell microgrids and localized green energy…

Continue Reading

TuesdayApr 23, 2024 9:45 am

Nutriband Inc. (NASDAQ: NTRB) Advances Abuse Deterrent Tech Addressing Fentanyl Epidemic

Fentanyl is a potent opioid that is associated with a significant risk of abuse and overdose, contributing to a major drug crisis in the United States Fentanyl has legitimate medical uses in managing severe and chronic pain in medical settings such as hospitals and surgical procedures NTRB is advancing its AVERSA(TM) technology that incorporates aversive agents to prevent abuse, diversion, misuse, and accidental exposure to opioids and other drugs with abuse potential NTRB was recently granted a patent for AVERSA(TM), strengthening its intellectual property portfolio in the United States and globally across 45 countries Fentanyl, a potent opioid, poses a…

Continue Reading

TuesdayApr 23, 2024 9:00 am

SuperCom Ltd. (NASDAQ: SPCB) Electronic Monitoring Technology Addresses Important Concerns in Dealing with Youthful Offenders

Developments in Australia’s efforts to limit youth offender recidivism underscore the importance of being able to track select probationary participants Israel-based SuperCom Ltd. is positioning itself to be a world leader in providing court-administered offender tracking, which may include youths potentially prone to recidivism The company is growing on a global scale with contracts in Romania, Finland, Croatia, Sweden, and various states in the United States, in a marketplace with an anticipated 9.5 percent CAGR over the next five years An Australian court’s decision to have young criminal suspects wear electronic ankle bracelet monitors is helping law enforcement advocates successfully…

Continue Reading

MondayApr 22, 2024 2:24 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Marks Phase One Completion of Battery Line Integration

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the first phase completion of battery line integration at its high energy facility located in Fullerton, California. According to the announcement, the southern California facility is dedicated to producing next-generation American-made EV battery packs, a critical component to Mullen’s commitment to zero emissions and to reducing reliance on key battery components imported from foreign countries. “Our new battery assembly plant is not just an investment in Mullen Automotive's future, but also a testament to our commitment towards U.S. battery production,” said David Michery, CEO of Mullen Automotive. “Battery…

Continue Reading

MondayApr 22, 2024 12:00 pm

Energy and Water Development Corp. (EAWD) Is ‘One to Watch’

EAWD is a green-tech engineering solutions company that builds water and energy systems for clients, including private companies, government entities and NGOs The company has sold and deployed its water systems in Mexico and Germany Using its patent-pending design, EAWD is working to build and operate off-grid EV charging stations in Germany In December 2023, the company announced a joint Memorandum of Understanding to build the first off-grid atmosphere water generation plant in North America Energy and Water Development (OTCQB: EAWD) is a green-tech engineering solutions company focused on delivering water and energy to extreme environments. The company builds water…

Continue Reading

MondayApr 22, 2024 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks GLP-1 Study Milestone with Ethics Review Board Approval

Lexaria, a global innovator in drug delivery platforms, has received approval for its GLP-1 human pilot study #2 by an independent third-party ethics review board GLP-1 drugs are utilized in the treatment of type 2 diabetes and obesity, a huge market, and are typically administered by painful and expensive injection, offering a major opportunity for Lexaria’s oral delivery platform This approval sets the company up for dosing within 30 days or less, with tentative study completion dates for this summer The study will comprise two study arms, the second study arm will investigate whether Lexaria’s patented DehydraTECH(TM)-enhanced semaglutide can effectively…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered